Pharmaceutical giant Pfizer has initiated a massive global agency review expected to encompass media, creative, PR and production duties in a holding company consolidation play, according to multiple people familiar with the matter.
Pharmaceutical giant Pfizer has initiated a massive global agency review expected to encompass media, creative, PR and production duties in a holding company consolidation play, according to multiple people familiar with the matter.
Pete Lempert, who took over as CEO of TRG in March, explains how he's getting the agency back on the industry's radar five years after its founder's resignation.